---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-000201"
form_type: "8-K"
ticker: "AMRN"
cik: "0000897448"
company_name: "AMARIN CORP PLCUK"
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:44:38.107263+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Amarin reports preliminary 2021 revenue ~$580M, appoints Per Wold-Olsen to board

## Summary
- Full-year 2021 net revenue ~$580M; Q4 revenue ~$140M, stable vs Q3.
- Ended 2021 with ~$490M cash/investments and no debt.
- Plans to develop fixed-dose combination of VASCEPA and a statin.
- Per Wold-Olsen appointed to Board effective Jan 10, 2022; receives $540K in equity awards.
- 2022 revenue guidance not provided due to COVID/generic uncertainty; US ops expect positive contribution margin.

## SEC filing metadata
- accession: 0000950170-22-000201
- form_type: 8-K
- ticker: AMRN
- cik: 0000897448
- company_name: AMARIN CORP PLCUK
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/897448/000095017022000201/0000950170-22-000201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/897448/000095017022000201/amrn-20220109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-000201
- JSON: https://secwatch.observer/filing/0000950170-22-000201.json
- Plain text: https://secwatch.observer/filing/0000950170-22-000201.txt

## Key facts
- Executive change
  Per Wold-Olsen was appointed as Director at AMARIN CORP PLCUK.
  - Action: appointed
  - Role: Director
  source text: On January 9, 2022, the Board, in accordance with the Company’s articles of association and upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Per Wold-Olsen as a Director of the Company, effective as of January 10, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/897448/000095017022000201/0000950170-22-000201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.